SCHEMBL19862801

SCHEMBL19862801

CC(C)(C)c1cc(-c2ccc(-c3ccccc3)cc2)nc(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.53
KMT2A Q03164 9/20 0.53
HPGD P15428 6/20 0.53
ALDH1A1 P00352 5/20 0.53
MAPT P10636 5/20 0.53
NTSR1 P30989 1/20 0.53
ADORA1 P30542 3/20 0.50
ADORA2A P29274 1/20 0.50
HSD17B10 Q99714 3/20 0.47
KDM4E B2RXH2 4/20 0.47
LMNA P02545 3/20 0.46
POLB P06746 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
CYP2C19 P33261 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
GLA P06280 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPK1 P28482 2/20 0.45
S1PR4 O95977 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24795101 1.00 MEN1 (0.53) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL15745464 0.96 ADORA1 (0.53) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL22960339 0.90 LMNA (0.44) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18326860 0.88 HSD17B10 (0.43) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL24795075 0.87 CYP1A1 (0.51) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL25817273 0.87 L3MBTL1 (0.50) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL22058528 0.82 MEN1 (0.58) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19862803 0.82 MEN1 (0.58) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL17829249 0.81 MEN1 (0.53) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL12306206 0.80 MEN1 (0.76) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885HPGD 2720/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885HPGD 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.